Activation of Retinoid X Receptor by Bexarotene Attenuates Neuroinflammation Via PPARγ/SIRT6/FoxO3a Pathway After Subarachnoid Hemorrhage in Rats

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2019 Feb 23

PMID 30791908

Citations 44

Authors

Yuchun Zuo

Lei Huang

Budbazar Enkhjargal

Weilin Xu

Ocak Umut

Zachary D Travis

Guangyu Zhang

Jiping Tang

Fei Liu

John H Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Subarachnoid hemorrhage (SAH) is a life-threatening subtype of stroke with high mortality and disabilities. Retinoid X receptor (RXR) has been shown to be neuroprotective against ischemia/reperfusion injury. This study aimed to investigate the effects of the selective RXR agonist bexarotene on neuroinflammation in a rat model of SAH.

Methods: Two hundred male Sprague-Dawley rats were used. The endovascular perforation induced SAH. Bexarotene was administered intraperitoneally at 1 h after SAH induction. To investigate the underlying mechanism, the selective RXR antagonist UVI3003 and RXR siRNA or SIRT6 inhibitor OSS128167 was administered via intracerebroventricular 1 h before SAH induction. Post-SAH assessments including SAH grade, neurological score, brain water content, Western blot, and immunofluorescence were performed.

Results: The endogenous RXR and sirtuin 6 (SIRT6) protein levels were increased after SAH. Bexarotene treatment significantly reduced brain edema and improved the short-/long-term neurological deficit after SAH. Mechanistically, bexarotene increased the levels of PPARγ and SIRT6; decreased the expression of phosphorylated FoxO3a (p-FoxO3a), IL-6, IL-1β, and TNF-a; and inhibited the microglia activation and neutrophils infiltration at 24 h after SAH. Either UVI3003, OSS128167, or RXR siRNA abolished the neuroprotective effects of bexarotene and its regulation on protein levels of PPARγ/SIRT6/p-FoxO3a after SAH.

Conclusions: The activation of RXR by bexarotene attenuated neuroinflammation and improved neurological deficits after SAH. The anti-neuroinflammatory effect was at least partially through regulating PPARγ/SIRT6/FoxO3a pathway. Bexarotene may be a promising therapeutic strategy in the management of SAH patients.

Citing Articles

Retinoid X receptor agonist 9CDHRA mitigates retinal ganglion cell apoptosis and neuroinflammation in a mouse model of glaucoma.

Basavarajappa D, Chitranshi N, Oddin Mirshahvaladi S, Gupta V, Palanivel V, Parrilla G FASEB J. 2025; 39(6):e70465.

PMID: 40079201 PMC: 11904862. DOI: 10.1096/fj.202402642R.

Research progress of early brain Injury in subarachnoid hemorrhage from 2004 to 2024: a bibliometric analysis.

Ye H, Wang X, Xie W, Fu W, Liang Y, Tan J Neurosurg Rev. 2025; 48(1):75.

PMID: 39847142 DOI: 10.1007/s10143-025-03233-6.

Deacetylase SIRT2 Inhibition Promotes Microglial M2 Polarization Through Axl/PI3K/AKT to Alleviate White Matter Injury After Subarachnoid Hemorrhage.

Yuan K, Wu Q, Yao Y, Shao J, Zhu S, Yang J Transl Stroke Res. 2024; .

PMID: 39103659 DOI: 10.1007/s12975-024-01282-5.

PEDF-34 attenuates neurological deficit and suppresses astrocyte-dependent neuroinflammation by modulating astrocyte polarization via 67LR/JNK/STAT1 signaling pathway after subarachnoid hemorrhage in rats.

Wu L, Liu Y, He Q, Ao G, Xu N, He W J Neuroinflammation. 2024; 21(1):178.

PMID: 39034417 PMC: 11264993. DOI: 10.1186/s12974-024-03171-y.

The pivotal role of microglia in injury and the prognosis of subarachnoid hemorrhage.

Ning W, Lv S, Wang Q, Xu Y Neural Regen Res. 2024; 20(7):1829-1848.

PMID: 38993136 PMC: 11691474. DOI: 10.4103/NRR.NRR-D-24-00241.

References

Maden M . Retinoid signalling in the development of the central nervous system. Nat Rev Neurosci. 2002; 3(11):843-53. DOI: 10.1038/nrn963. View

van Gijn J, Kerr R, Rinkel G . Subarachnoid haemorrhage. Lancet. 2007; 369(9558):306-18. DOI: 10.1016/S0140-6736(07)60153-6. View

Sugawara T, Ayer R, Jadhav V, Zhang J . A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods. 2007; 167(2):327-34. PMC: 2259391. DOI: 10.1016/j.jneumeth.2007.08.004. View

Altucci L, Leibowitz M, Ogilvie K, de Lera A, Gronemeyer H . RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov. 2007; 6(10):793-810. DOI: 10.1038/nrd2397. View

Shen H, Luo Y, Kuo C, Deng X, Chang C, Harvey B . 9-Cis-retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein. J Neurosci Res. 2008; 87(2):545-55. PMC: 2628966. DOI: 10.1002/jnr.21865. View

Collino M, Patel N, Thiemermann C . PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury. Ther Adv Cardiovasc Dis. 2009; 2(3):179-97. DOI: 10.1177/1753944708090924. View

Huang W, Glass C . Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol. 2010; 30(8):1542-9. PMC: 2911147. DOI: 10.1161/ATVBAHA.109.191189. View

Pino-Lagos K, Guo Y, Noelle R . Retinoic acid: a key player in immunity. Biofactors. 2010; 36(6):430-6. PMC: 3826167. DOI: 10.1002/biof.117. View

Yang S, Choi J, Chae S, Kim W, Park S, Rhee E . Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats. PLoS One. 2011; 6(2):e17057. PMC: 3044155. DOI: 10.1371/journal.pone.0017057. View

10.

Lin Y, Jones B, Liu A, Tucker J, Rapp K, Luo L . Retinoid receptors trigger neuritogenesis in retinal degenerations. FASEB J. 2011; 26(1):81-92. PMC: 3250249. DOI: 10.1096/fj.11-192914. View

11.

Cramer P, Cirrito J, Wesson D, Lee C, Karlo J, Zinn A . ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science. 2012; 335(6075):1503-6. PMC: 3651582. DOI: 10.1126/science.1217697. View

12.

Cambray S, Arber C, Little G, Dougalis A, de Paola V, Ungless M . Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors. Nat Commun. 2012; 3:841. DOI: 10.1038/ncomms1817. View

13.

Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso J . Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. J Neurochem. 2013; 125(3):410-9. PMC: 3642978. DOI: 10.1111/jnc.12190. View

14.

Roszer T, Menendez-Gutierrez M, Cedenilla M, Ricote M . Retinoid X receptors in macrophage biology. Trends Endocrinol Metab. 2013; 24(9):460-8. DOI: 10.1016/j.tem.2013.04.004. View

15.

Altay O, Suzuki H, Hasegawa Y, Ostrowski R, Tang J, Zhang J . Isoflurane on brain inflammation. Neurobiol Dis. 2013; 62:365-71. PMC: 3919516. DOI: 10.1016/j.nbd.2013.09.016. View

16.

Jiang Y, Wang J, Rozewski D, Kolli S, Wu C, Chen C . Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue. J Pharm Biomed Anal. 2013; 88:262-8. PMC: 3860284. DOI: 10.1016/j.jpba.2013.08.036. View

17.

Jawed S, Myskowski P, Horwitz S, Moskowitz A, Querfeld C . Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014; 70(2):223.e1-17. DOI: 10.1016/j.jaad.2013.08.033. View

18.

Muroi C, Fujioka M, Mishima K, Irie K, Fujimura Y, Nakano T . Effect of ADAMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hemorrhage. J Thromb Haemost. 2014; 12(4):505-14. DOI: 10.1111/jth.12511. View

19.

Siler D, Gonzalez J, Wang R, Cetas J, Alkayed N . Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in mice. Transl Stroke Res. 2014; 5(2):227-37. PMC: 4012892. DOI: 10.1007/s12975-014-0329-y. View

20.

Zhao X, Gonzales N, Aronowski J . Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB. CNS Neurosci Ther. 2014; 21(4):357-66. PMC: 4376579. DOI: 10.1111/cns.12350. View